Chronic Myelogenous Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|8|1|3-13

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.8, Iss.1, 2012-02, pp. : 3-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Imatinib in the Treatment of Chronic Myelogenous Leukemia

By Dax Kurbegov   Hagop M. Kantarjian   Moshe Talpaz  

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 337-348

Adis International

Access to resources Recommend Favorite

Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib

By Mishima Y.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 168-171

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of microRNA and gene networks in human chronic myelogenous leukemia

By Wang Kunhao   Xu Zhiwen   Wang Ning   Tian Ye   Sun Xin   Ma Yonggang  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 453-460

Spandidos Publications

Access to resources Recommend Favorite

Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

By Deininger Michael  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 59-72

Springer Publishing Company

Access to resources Recommend Favorite